Genetic Technologies Announces Comprehensive Review of Strategic Alternatives
August 25, 2017 05:30 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Aug 25, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, and...
Genetic Technologies Launches Breast Cancer Awareness Month Promotion for BREVAGenplus(R)
August 01, 2017 08:30 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Aug 1, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company specialising in cancer genomics, and provider...
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017
July 27, 2017 19:41 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jul 27, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE)
HIGHLIGHTS
Revised BREVAGenplus® commercial...
Genetic Technologies Receives Nasdaq Deficiency Notice
July 21, 2017 21:57 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Jul 21, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), today announced that on 20 July 2017, it received a notification letter (the...
Genetic Technologies Revamps Patient Pricing and Billing Program for BREVAGenplus(R)
March 31, 2017 05:30 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Mar 31, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, and...
Genetic Technologies and IndyCar's Pippa Mann Partner for Second Consecutive Year to Promote BREVAGenplus(R)
March 29, 2017 05:30 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Mar 29, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, announced...
Genetic Technologies Announces Offering of USD 6.0 Million of American Depository Shares
December 01, 2016 09:07 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Dec 1, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company and provider of BREVAGenplus®, a...
Genetic Technologies Limited and The University of Melbourne Enter into Exclusive Worldwide License Agreement to Develop Colorectal Cancer Risk Assessment Test
November 29, 2016 05:30 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Nov 29, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company and provider of BREVAGenplus®, a...
Nohla Therapeutics Signs Exclusive Supply Agreement With LifeSouth Community Blood Centers
October 19, 2016 05:30 ET
|
Nohla Therapeutics
SEATTLE, WA--(Marketwired - Oct 19, 2016) - Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...
Genetic Technologies Launches BREVAGenplus(R) Marketing Program Around Susan G. Komen(R)'s Race for the Cure(R) Events
October 03, 2016 05:30 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Oct 3, 2016) - Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") announced today that it will be conducting a...